Suppliers / Century Pharmaceuticals

Century Pharmaceuticals

India 39 employees Updated 9 July 2026

Century Pharmaceuticals is an API and finished-dose manufacturer based in India. It holds 9 active US drug master files across a filed portfolio of 7 molecules. Its filings concentrate with MINSA (CR), BOMRA (BW) and CDSCO (India). Its GMP standing is certified by CDSCO (India). Its most recent recorded inspection, by US FDA, closed on 16 February 2023 as NAI. Customs aggregates show $7.7M of exports covering 518 molecules to 56 destinations in 2025.

9
active US DMFs
0
valid CEPs
3
registered plants 1 with an FDA FEI number
6
filings across 3 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
7 of 7 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 16 February 2023 NAI US FDA
  • 15 February 2018 NAI US FDA
  • 31 March 2016 VAI US FDA
  • 14 January 2014 VAI US FDA
  • 16 September 2011 VAI US FDA
  • 14 July 2010 VAI US FDA
  • 13 November 2008 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Panchmahal, India Not on file
Gidc, India Not on file
Indianapolis, United States 1819174

What they file, and where

Molecule Regulators Docs
Erythromycin US FDA 3
Oxytetracycline US FDA 2
Alfacalcidol SFDA (Saudi Arabia) 1
Azithromycin US FDA 1
Clarithromycin US FDA 1
Dorzolamide US FDA 1
Roxithromycin US FDA 1

Also appears on these molecule pages

Azithromycin API Clarithromycin API Dorzolamide API Erythromycin API Molnupiravir finished dose Oxytetracycline API Roxithromycin API

Filings and GMP by regulator

Regulator Filings GMP certificates
MINSA (CR) 3 None
BOMRA (BW) 2 None
CDSCO (India) 1 2

Scale

Year Revenue Exports Destinations
2026 YTD Not reported $2.2M 27
2025 Not reported $7.7M 56
2024 Not reported $11.5M 50
2023 Not reported $7.2M 42

Export figures are customs aggregates. We do not publish the identity of any buyer.

Questions about Century Pharmaceuticals

Does Century Pharmaceuticals hold a US DMF or a CEP?
Century Pharmaceuticals holds 9 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Is Century Pharmaceuticals FDA-registered?
One site operated by Century Pharmaceuticals carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Century Pharmaceuticals's last inspection go?
The most recent inspection on record closed on 16 February 2023 as NAI (No Action Indicated: nothing objectionable was found). 7 inspections are on file.
Where does Century Pharmaceuticals manufacture?
3 registered sites are on record, in India and United States (Panchmahal, Gidc and Indianapolis). Every site is listed on this page with the register it came from.
What does Century Pharmaceuticals make?
7 molecules are on record against Century Pharmaceuticals, including Erythromycin, Oxytetracycline, Alfacalcidol and Azithromycin. Each links through to that molecule's full manufacturer list.
Which regulators recognise Century Pharmaceuticals's GMP?
Current GMP certificates are on record from CDSCO (India). GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Century Pharmaceuticals comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was NAI, on 16 February 2023.

Comparable suppliers

Alembic Pharmaceuticals shares 4 molecules HEC Pharm shares 3 molecules Zhejiang Guobang shares 3 molecules Ercros shares 3 molecules Calyx Chemicals and Pharmaceuticals shares 2 molecules

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates
Customs aggregates
Export values, molecule and destination counts